Watch Ticker

Shattuck Labs, Inc. Common Stock

Go to Shattuck Labs, Inc. Common Stock Website

$10.59

(%)

Live

Previous Close

$10.59

Day Range

$ - $

Previous Day Range

$ - $

Market Cap

$503.6 million USD

Day Vol.

Previous Day Vol.

Currency

USD

Primary Exchange

Nasdaq

Shattuck Labs Inc is a clinical-stage biotechnology company pioneering the development of dual-sided fusion proteins as an entirely new class of biologic medicine. Its product candidate, SL-172154, has been rationally designed to simultaneously inhib...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Shattuck Labs, Inc. - Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024

– Aberrant TRIM7 expression identified as a key driver of immune checkpoint blockade (ICB) acquired resistance; inhibition of TRIM7 with small molecule inhibitors may prevent or reverse acquired resistance to PD-1/L1 blockade –

Related tickers: STTK.

Read Full Article

Shattuck Labs, Inc. - Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare Conference

AUSTIN, TX & DURHAM, NC, April 01, 2024 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a clinical-stage biotechnology company pioneering the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease, today announced that company management will participate in the 23rd Annual Needham Virtual Healthcare Conference being held virtually from April 8-11, 2024.

Related tickers: STTK.

Read Full Article

Trending Tickers

DATS

XNAS

$1.24

(%)

LASE

XNAS

$2.10

(%)

NYCB

XNYS

$2.97

(%)

PACW

XNAS

$7.54

(%)

MLGO

XNAS

$0.00

(%)